Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates

Press/Media

Period	18 Dec 2023

Media coverage

Title	Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Media name/outlet	BioSpace
Country/Territory	United States
Date	18/12/23
URL	ct.moreover.com/?a=52623458167&p=1gw&v=1&x=Sr4eayc8uITu1FCBZItVdw
Persons	Emmanuel Petricoin